In a heavy blow to illicit pharmaceutical operations, two Miami men have received federal prison sentences for their involvement in schemes that endangered patient health and violated drug safety regulations. Boris Arencibia, 52, and Jose Armando Rivera Garcia, 45, were sentenced on Oct. 30 to 57 months each for their roles in a $28 million operation trafficking misbranded and diverted prescription drugs, some used to treat life-threatening conditions like HIV and cancer, as reported by the U.S. Attorney's Office.
The pharmaceutical drugs, which demand precise storage to maintain efficacy, were purchased from unauthorized street sources and stored without care. According to the U.S. Attorney's Office, "Diverted drugs put patients' lives at risk." U.S. Attorney Jason A. Reding Quiñones for the Southern District of Florida emphasized the nefarious nature of the conspiracy, with the defendants knowingly circulating tainted medications nationwide.
The drugs in question were repackaged and accompanied by falsified documents to mimic legitimate supply chains, ultimately being sold to pharmacies and unsuspecting patients across the United States. The counterfeit drugs posed serious health risks, instances revealing bottles containing incorrect medications, vitamins, and in some egregious cases, mere pebbles. The scheme, unveiled in two indictments—one in 2019 with 20 defendants and the other filed in 2025—showcased an extensive network of crime, deception, and disregard for human life.
Arencibia and Rivera Garcia plead guilty to multiple charges, including conspiracy to commit money laundering and trafficking medical products with falsified documentation. The court inflicted 57 months of prison time in the 2019 case to be served concurrently with the 43-month terms from the 2025 case. The investigations, led by various federal agencies, demonstrate a coalition force among FDA-OCI, FBI Miami, and HHS-OIG in rooting out the corruption embedded in the supposed haven of healthcare.
U.S. District Judge Darrin P. Gayles meted out the sentences, addressing the gravity of the offense and the necessity for justice. The announcement was made by the officials from the FDA, HHS-OIG, and the FBI. Further details on the cases can be found on the website of the District Court for the Southern District of Florida.
